GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern California looked at a positive side

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research. The study was small — just 48 adults — and lasted just over two months,

Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving people with moderate alcohol use disorder,